EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Assessing the diagnostic performance of clinical, serological and molecular approaches to improve dengue case detection in the Peruvian Amazon

Anne Hauner iD, Jaide Aroni-Sierra, Xiomara Merino, Carlos Villa, Fiorella Torres, Ole Lagatie, Michael Talledo, Kevin K Ariën, Francesca Falconi-Agapito

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0013984 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Anne Hauner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Hauptthemen laut MEDLINE: Dengue, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals NV, Belgian Directorate-general Development Cooperation and Humanitarian Aid, Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In dengue endemic, resource-limited settings, accurate and timely diagnosis is critical for effective clinical management and outbreak control, especially where multiple arboviruses co-circulate and overlap in clinical presentations. However, most dengue diagnosis in such settings rely on approaches with limited sensitivity such as clinical assessment, or easily deployable methods such as ELISA or rapid diagnostic tests (RDTs). Molecular diagnostics with superior diagnostic performance are rarely implemented beyond reference laboratories due to perceived logistical and operational barriers. This study provides real-world evidence comparing the performance of clinical, serological and molecular approaches for dengue diagnosis in a decentralized setting. We prospectively enrolled 271 patients with acute febrile illness at Santa Gema Hospital in Yurimaguas, Peru, during a dengue outbreak in 2023–2024. Patients underwent clinical evaluation (WHO 2009 dengue classification), and laboratory testing including NS1/ IgM RDTs and ELISAs, a triplex RT-PCR for ZIKV/DENV/CHIKV (ZDC-PCR), a newly developed multiplex RT-PCR for ZIKV/YFV/DENV/CHIKV (ZYDC-PCR), and a serotype-specific dengue RT-PCR used as reference. Diagnostic performance was assessed using sensitivity, specificity, ROC-AUC analysis, and logistic regression models. A subset of 131 samples underwent inter-laboratory comparison of the ZYDC-PCR between the regional (Yurimaguas) and central (Lima) laboratories. Of the 271 dengue-suspected cases, 88 (32.6%) were confirmed by the reference PCR. The ZYDC-PCR had a strong agreement with the reference (sensitivity 86.0%, Cohen’s kappa 0.893) and consistent performance across the central and regional laboratory. NS1-based tests showed high specificity (≥96%) but moderate sensitivity (~72%). ROC analysis confirmed the accuracy of PCR (AUC = 0.97), outperforming RDTs, ELISAs (AUC = 0.85 to 0.89) and clinical assessment (AUC = 0.65). Our study demonstrates the added value and feasibility of implementing a multiplex PCR at a regional hospital to significantly improve diagnostic accuracy, enabling earlier detection of disease presence or absence, critical for clinical management and outbreak response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueMolecular Diagnostic TechniquesHumansPeruFemaleMaleSensitivity and SpecificityDengue VirusProspective StudiesAdultAdolescentSerologic TestsYoung AdultEnzyme-Linked Immunosorbent AssayMiddle AgedAntibodies, ViralRapid Diagnostic TestsChildChild, PreschoolDisease OutbreaksROC Curve

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Laboratorio HSG, Hospital Santa Gema, Yurimaguas, Peru.
  • Oficina de Epidemiología, Hospital Santa Gema, Yurimaguas, Peru.
  • Department of Communicable Diseases, Johnson and Johnson, Beerse, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Anne Hauner

Förderung

  • Janssen Pharmaceuticals NV
  • Belgian Directorate-general Development Cooperation and Humanitarian Aid
  • Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
  • Fonds voor Wetenschappelijk Onderzoek - Vlaanderen

Zitieren

APA

Hauner, A., Aroni-Sierra, J., Merino, X., Villa, C., Torres, F., Lagatie, O., Talledo, M., Ariën, K. K., & Falconi-Agapito, F. (2026). Assessing the diagnostic performance of clinical, serological and molecular approaches to improve dengue case detection in the Peruvian Amazon. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013984

Vancouver

Hauner A, Aroni-Sierra J, Merino X, Villa C, Torres F, Lagatie O, et al. Assessing the diagnostic performance of clinical, serological and molecular approaches to improve dengue case detection in the Peruvian Amazon. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0013984

BibTeX
@article{Hauner2026,
  author = {Hauner, Anne and Aroni-Sierra, Jaide and Merino, Xiomara and Villa, Carlos and Torres, Fiorella and Lagatie, Ole and Talledo, Michael and Ariën, Kevin K and Falconi-Agapito, Francesca},
  title = {Assessing the diagnostic performance of clinical, serological and molecular approaches to improve dengue case detection in the Peruvian Amazon},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0013984}
}
Kostenlos starten →